Skip to content
OpenCapital
Get started

Maravai LifeSciences Holdings, Inc. MRVI EV / sales

EV / sales at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
5.1×-0.9×
Danaher logo
DanaherDHR
6×-0.8×
Repligen logo
RepligenRGEN
12.2×-0.3×
ADMA Biologics logo
ADMA BiologicsADMA
4.3×-5.8×
Revvity logo
RevvityRVTY
4.4×-0.9×
TEC
Bio-TechneTECH
6.8×-1.1×

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+204%
Enterprise value$954.59M+198%
P/S4.2×+3.0×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%—

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.

enterprise value/total revenue=2.5×

Based on the most recent quarter.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s EV / sales?
Maravai LifeSciences Holdings, Inc. (MRVI) reported EV / sales of 2.5× in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s EV / sales changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s EV / sales increased by 70.8% year-over-year, from 1.5× to 2.5×.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s EV / sales?
Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s EV / sales has grown at a -29.7% compound annual growth rate (CAGR), from 19.4× to 3.3×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.